IL6 and central nervous system cancer: This study showed that patients with high levels of hs-CRP and IL-6 expression were more likely to enter the moderate or high symptom groups, suggesting that inflammatory markers play a role in the pathogenesis of psychoneurological symptom clusters, which is consistent with findings in head and neck cancer and glioma (Li et al., 2023).